Rumor Has It: Can Biogen Find A Buyer For Hemophilia Drugs?
This article was originally published in Scrip
It's no secret that Biogen Inc. has been facing some issues over the last year as shares have dropped, management has exited and the company has made staffing cuts, but the latest rumors have the big biotech selling off one of its lucrative franchises. The move would not only be a drastic shift for the company, but begs the question: who would buy?
Register for our free email digests: